QuidelOrtho Corp·4

Jun 9, 4:07 PM ET

WIDDER KENNETH J 4

Research Summary

AI-generated summary

Updated

QuidelOrtho (QDEL) Director Kenneth Widder Receives 1,183 Shares

What Happened
Kenneth J. Widder, a director of QuidelOrtho Corporation (QDEL), had a total of 1,183 restricted stock units (910 + 273) released on June 6, 2026. The filing shows these RSUs converted into 1,183 common shares at $0.00 per share (total $0), reflecting vested awards previously reported. This was not a purchase or a sale — it was the delivery of shares from previously awarded RSUs under the company’s director deferred compensation program.

Key Details

  • Transaction date: June 6, 2026; Form 4 filed June 9, 2026 (timely).
  • Reported entries: two Award/Acquisition (code A) entries for 910 and 273 shares @ $0.00; two Exercise/Conversion (code M) entries for the same amounts (reflecting conversion of derivative RSUs).
  • Total shares received: 1,183 shares; total reported cash value: $0.00 (these were previously granted awards).
  • Footnotes: F1–F3 state these were releases of previously reported RSUs, each RSU equals one share, and the release was deferred per the non-employee director deferred compensation program and occurred per the elected schedule.
  • Shares owned after the transaction: not specified in the information provided.

Context
The filing shows conversion/release of deferred RSUs rather than an open-market buy or sale. The dual M (conversion) and A (acquisition) entries are common when derivative awards (RSUs) are converted to actual shares and then delivered. There is no indication the shares were immediately sold (i.e., this is not a cashless exercise or disposition). This is routine compensation-related insider reporting, not necessarily a signal of buying or selling intent.